Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study-Reference-Cited by-同舟云学术

Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

Published:2016-12 Issue:12 Volume:17 Page:1672-1682
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Gomez Daniel R,Blumenschein George R,Lee J Jack,Hernandez Mike,Ye Rong,Camidge D Ross,Doebele Robert C,Skoulidis Ferdinandos,Gaspar Laurie E,Gibbons Don L,Karam Jose A,Kavanagh Brian D,Tang Chad,Komaki Ritsuko,Louie Alexander V,Palma David A,Tsao Anne S,Sepesi Boris,William William N,Zhang Jianjun,Shi Qiuling,Wang Xin Shelley,Swisher Stephen G,Heymach John V

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis;Rusthoven;Acta Oncol,2009

2. Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT);Wong;Cancer,2016

3. MicroRNA expression characterizes oligometastasis(es);Lussier;PLoS One,2011

4. An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease;Salama;Clin Cancer Res,2008

5. Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions;Inoue;Jpn J Clin Oncol,2010

Cited by 900 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort;Radiotherapy and Oncology;2024-10

2. Efficacy and safety of anlotinib as maintenance therapy in patients with advanced non-small cell lung cancer achieving SD post first-line chemotherapy combined with immunotherapy;Journal of Chemotherapy;2024-09

3. The significance of consolidation chemotherapy after concurrent chemoradiotherapy in esophageal squamous cell carcinoma: a randomized controlled phase III clinical trial;Thoracic Cancer;2024-08-28

4. Appropriate delay of primary tumour radiotherapy may lead to better long-term overall survival for non-small cell lung cancer treated with EGFR-TKIs;BMC Cancer;2024-08-26

5. Use of Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy for Oligometastatic Lung Adenocarcinoma: Leveraging CT-Guided Online Adaptive Radiotherapy;Cureus;2024-08-14